AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 26-50/51
CARBONYL IRON SUPPLEMENTATION FOR FEMALE BLOOD-DONORS
Authors: BRITTENHAM GM GORDEUK VR BRAVO JR HIRSCHLER NV PILIAVIN JA GOORMASTIC M KEATING LJ
Citation: Gm. Brittenham et al., CARBONYL IRON SUPPLEMENTATION FOR FEMALE BLOOD-DONORS, Blood, 88(10), 1996, pp. 3085-3085
LONG-TERM COMPLICATIONS OF BONE-MARROW TRANSPLANTATION (BMT) IN IRON-LOADED PATIENTS
Authors: ANDERSON R BASRAN R BLANCHETTE N KLEIN N MUROFF A AMYLON M BRITTENHAM GM MENTZER W VICHINSKY EP OLIVIERI NF
Citation: R. Anderson et al., LONG-TERM COMPLICATIONS OF BONE-MARROW TRANSPLANTATION (BMT) IN IRON-LOADED PATIENTS, Blood, 88(10), 1996, pp. 1037-1037
FIRST REPORT OF LONG-TERM ELIMINATION OF RED-CELL TRANSFUSIONS IN THALASSEMIA MAJOR THROUGH AUGMENTATION OF FETAL HEMOGLOBIN WITH SODIUM PHENYLBUTYRATE (SPB) AND HYDROXYUREA (HU)
Authors: OLIVIERI NF REES DC GINDER GD THEIN SL WAYE JS CHANG L BRITTENHAM GM DOVER GJ WEATHERALL DJ
Citation: Nf. Olivieri et al., FIRST REPORT OF LONG-TERM ELIMINATION OF RED-CELL TRANSFUSIONS IN THALASSEMIA MAJOR THROUGH AUGMENTATION OF FETAL HEMOGLOBIN WITH SODIUM PHENYLBUTYRATE (SPB) AND HYDROXYUREA (HU), Blood, 88(10), 1996, pp. 1227-1227
COADMINISTRATION OF DESFERRIOXAMINE-B WITH ARTESUNATE IN MALARIA - ANASSESSMENT OF SAFETY AND TOLERANCE
Authors: LOOAREESUWAN S WILAIRATANA P VANNAPHAN S GORDEUK VR TAYLOR TE MESHNICK SR BRITTENHAM GM
Citation: S. Looareesuwan et al., COADMINISTRATION OF DESFERRIOXAMINE-B WITH ARTESUNATE IN MALARIA - ANASSESSMENT OF SAFETY AND TOLERANCE, Annals of tropical medicine and parasitology, 90(5), 1996, pp. 551-554
GIANT MITOCHONDRIA INDUCED IN RAT PANCREATIC EXOCRINE CELLS BY ETHANOL AND IRON
Authors: TANDLER B HORNE WI BRITTENHAM GM TSUKAMOTO H
Citation: B. Tandler et al., GIANT MITOCHONDRIA INDUCED IN RAT PANCREATIC EXOCRINE CELLS BY ETHANOL AND IRON, The Anatomical record, 245(1), 1996, pp. 65-75
PRIMARY IRON OVERLOAD IN AFRICAN-AMERICANS
Authors: WURAPA RK GORDEUK VR BRITTENHAM GM KHIYAMI A SCHECHTER GP EDWARDS CQ
Citation: Rk. Wurapa et al., PRIMARY IRON OVERLOAD IN AFRICAN-AMERICANS, The American journal of medicine, 101(1), 1996, pp. 9-18
IRON-CHELATION THERAPY WITH ORAL DEFERIPRONE IN PATIENTS WITH THALASSEMIA MAJOR
Authors: OLIVIERI NF BRITTENHAM GM MATSUI D BERKOVITCH M BLENDIS LM CAMERON RG MCCLELLAND RA LIU PP TEMPLETON DM KOREN G
Citation: Nf. Olivieri et al., IRON-CHELATION THERAPY WITH ORAL DEFERIPRONE IN PATIENTS WITH THALASSEMIA MAJOR, The New England journal of medicine, 332(14), 1995, pp. 918-922
EXPERIMENTAL LIVER-CIRRHOSIS INDUCED BY ALCOHOL AND IRON
Authors: TSUKAMOTO H HORNE W KAMIMURA S NIEMELA O PARKKILA S YLAHERTTUALA S BRITTENHAM GM
Citation: H. Tsukamoto et al., EXPERIMENTAL LIVER-CIRRHOSIS INDUCED BY ALCOHOL AND IRON, The Journal of clinical investigation, 96(1), 1995, pp. 620-630
PREVALENCE OF HETEROZYGOTES FOR HEMOCHROMATOSIS IN THE WHITE-POPULATION OF THE UNITED-STATES
Authors: MCLAREN CE GORDEUK VR LOOKER AC HASSELBLAD V EDWARDS CQ GRIFFEN LM KUSHNER JP BRITTENHAM GM
Citation: Ce. Mclaren et al., PREVALENCE OF HETEROZYGOTES FOR HEMOCHROMATOSIS IN THE WHITE-POPULATION OF THE UNITED-STATES, Blood, 86(5), 1995, pp. 2021-2027
FIRST PROSPECTIVE RANDOMIZED TRIAL OF THE IRON CHELATORS DEFERIPRONE (L1) AND DEFEROXAMINE
Authors: OLIVIERI NF BRITTENHAM GM ARMSTRONG SAM BASRAN RK DANEMAN R DANEMAN N IWANCHKO RM TALBOT AL KOREN G
Citation: Nf. Olivieri et al., FIRST PROSPECTIVE RANDOMIZED TRIAL OF THE IRON CHELATORS DEFERIPRONE (L1) AND DEFEROXAMINE, Blood, 86(10), 1995, pp. 983-983
TRANSFERRIN SATURATION AND RECOVERY FROM COMA IN CEREBRAL MALARIA
Authors: GORDEUK VR THUMA PE MCLAREN CE BIEMBA G ZULU S POLTERA AA ASKIN JE BRITTENHAM GM
Citation: Vr. Gordeuk et al., TRANSFERRIN SATURATION AND RECOVERY FROM COMA IN CEREBRAL MALARIA, Blood, 85(11), 1995, pp. 3297-3301
NEED FOR EARLY, LOW-DOSE CHELATION-THERAPY IN YOUNG-CHILDREN WITH TRANSFUSED HOMOZYGOUS BETA-THALASSEMIA (HBT)
Authors: BERKOVITCH M BRITTENHAM GM KOREN G OLIVIERI NF
Citation: M. Berkovitch et al., NEED FOR EARLY, LOW-DOSE CHELATION-THERAPY IN YOUNG-CHILDREN WITH TRANSFUSED HOMOZYGOUS BETA-THALASSEMIA (HBT), Pediatric research, 35(4), 1994, pp. 10000157-10000157
REDUCTION IN HEPATIC IRON STORES WITH THE ORAL IRON CHELATOR-L1 IN PATIENTS (PTS) WITH TRANSFUSION-DEPENDENT THALASSEMIA (HBT) AND SICKLE-CELL DISEASE (SCD) - 1ST 3 YEARS OF THE CANADIAN TRIAL
Authors: BERKOVITCH M OLIVIERI NF BRITTENHAM GM KOREN G
Citation: M. Berkovitch et al., REDUCTION IN HEPATIC IRON STORES WITH THE ORAL IRON CHELATOR-L1 IN PATIENTS (PTS) WITH TRANSFUSION-DEPENDENT THALASSEMIA (HBT) AND SICKLE-CELL DISEASE (SCD) - 1ST 3 YEARS OF THE CANADIAN TRIAL, Pediatric research, 35(4), 1994, pp. 10000158-10000158
EFFICACY OF DEFEROXAMINE IN PREVENTING COMPLICATIONS OF IRON OVERLOADIN PATIENTS WITH THALASSEMIA MAJOR
Authors: BRITTENHAM GM GRIFFITH PM NIENHUIS AW MCLAREN CE YOUNG NS TUCKER EE ALLEN CJ FARRELL DE HARRIS JW
Citation: Gm. Brittenham et al., EFFICACY OF DEFEROXAMINE IN PREVENTING COMPLICATIONS OF IRON OVERLOADIN PATIENTS WITH THALASSEMIA MAJOR, The New England journal of medicine, 331(9), 1994, pp. 567-573
EARLY DETECTION OF THE DEVELOPMENT OF IRON-DEFICIENCY BY PATIENT-SPECIFIC SEQUENTIAL-ANALYSIS OF HEMATOLOGICAL TESTS
Authors: MCLAREN GD MCLAREN CE KAMBOUR EL LUKASKI HC XIA L MCLACHLAN GJ BRITTENHAM GM
Citation: Gd. Mclaren et al., EARLY DETECTION OF THE DEVELOPMENT OF IRON-DEFICIENCY BY PATIENT-SPECIFIC SEQUENTIAL-ANALYSIS OF HEMATOLOGICAL TESTS, Clinical research, 42(3), 1994, pp. 10000405-10000405
EVIDENCE OF REDUCTION IN HEPATIC, CARDIAC AND PITUITARY IRON STORES IN PATIENTS WITH THALASSEMIA MAJOR DURING LONG-TERM THERAPY WITH THE ORALLY-ACTIVE IRON-CHELATING AGENT L1
Authors: OLIVIERI NF BELLUZZO N MURACA M MACKENZIE CC MILONE SD POLSINELLI K KOREN G LIU PP BRITTENHAM GM
Citation: Nf. Olivieri et al., EVIDENCE OF REDUCTION IN HEPATIC, CARDIAC AND PITUITARY IRON STORES IN PATIENTS WITH THALASSEMIA MAJOR DURING LONG-TERM THERAPY WITH THE ORALLY-ACTIVE IRON-CHELATING AGENT L1, Blood, 84(10), 1994, pp. 10000109-10000109
EARLY DETECTION OF THE DEVELOPMENT OF IRON-DEFICIENCY BY PATIENT-SPECIFIC SEQUENTIAL-ANALYSIS OF HEMATOLOGICAL TESTS
Authors: MCLAREN CE MCLAREN GD KAMBOUR EL MCLACHLAN GJ LUKASKI HC LI X BRITTENHAM GM
Citation: Ce. Mclaren et al., EARLY DETECTION OF THE DEVELOPMENT OF IRON-DEFICIENCY BY PATIENT-SPECIFIC SEQUENTIAL-ANALYSIS OF HEMATOLOGICAL TESTS, Blood, 84(10), 1994, pp. 10000116-10000116
DEFEROXAMINE-INDUCED VISUAL TOXICITY IN 2 UNIQUE CLINICAL SETTINGS - THE IMPORTANCE OF ONGOING ASSESSMENT OF BODY IRON BURDEN
Authors: SHER GD MURACA M SCOTT JG BUNCIC JR BRITTENHAM GM OLIVIERI NF
Citation: Gd. Sher et al., DEFEROXAMINE-INDUCED VISUAL TOXICITY IN 2 UNIQUE CLINICAL SETTINGS - THE IMPORTANCE OF ONGOING ASSESSMENT OF BODY IRON BURDEN, Blood, 84(10), 1994, pp. 10000258-10000258
SUCCESS, AND FAILURE, OF IRON CHELATION-THERAPY WITH THE ORALLY-ACTIVE IRON CHELATOR L1 IN 2 SISTERS
Authors: MACKINNON JA MILONE SD BRITTENHAM GM JACOB RA KUTNINK MA KOREN G OLIVIERI NF
Citation: Ja. Mackinnon et al., SUCCESS, AND FAILURE, OF IRON CHELATION-THERAPY WITH THE ORALLY-ACTIVE IRON CHELATOR L1 IN 2 SISTERS, Blood, 84(10), 1994, pp. 10000258-10000258
LONG-TERM TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) INTHALASSEMIA - REDUCTION IN REQUIREMENT FOR TRANSFUSION AND CHELATION-THERAPY
Authors: SHER GD OLIVIERI FA MCCUSKER PJ DOVER GJ ALI M BRITTENHAM GM OLIVIERI NF
Citation: Gd. Sher et al., LONG-TERM TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) INTHALASSEMIA - REDUCTION IN REQUIREMENT FOR TRANSFUSION AND CHELATION-THERAPY, Blood, 84(10), 1994, pp. 10000258-10000258
THE 1ST PROSPECTIVE RANDOMIZED TRIAL OF SUBCUTANEOUS DEFEROXAMINE ANDTHE ORALLY-ACTIVE IRON-CHELATING AGENT L1
Authors: OLIVIERI NF SHER GD MACKINNON JA POPE I ENTSUAH B SNIDER MA LEWIS N SHAW D BERKOVITCH M KOREN G BRITTENHAM GM
Citation: Nf. Olivieri et al., THE 1ST PROSPECTIVE RANDOMIZED TRIAL OF SUBCUTANEOUS DEFEROXAMINE ANDTHE ORALLY-ACTIVE IRON-CHELATING AGENT L1, Blood, 84(10), 1994, pp. 10000363-10000363
THE ACCURATE QUANTITATION OF TOTAL-BODY IRON BURDEN
Authors: SHER GD BELUZZO N MILONE SD PAPADOURIS D MURACA M MACKENZIE CC LIU P TEMPLETON DM BRITTENHAM GM OLIVIERI NF
Citation: Gd. Sher et al., THE ACCURATE QUANTITATION OF TOTAL-BODY IRON BURDEN, Blood, 84(10), 1994, pp. 10000363-10000363
IRON OVERLOAD IN AFRICAN-AMERICANS
Authors: WURAPA RK GORDEUK VR BRITTENHAM GM KHIYAMI A EDWARDS CQ
Citation: Rk. Wurapa et al., IRON OVERLOAD IN AFRICAN-AMERICANS, Blood, 82(10), 1993, pp. 10000095-10000095
REDUCTION IN HEPATIC IRON STORES WITH THE ORAL IRON CHELATOR L1 IN PATIENTS (PTS) WITH TRANSFUSION-DEPENDENT THALASSEMIA (HBT) AND SICKLE-CELL DISEASE (SCD) - 1ST 3 YEARS OF THE CANADIAN TRIAL
Authors: OLIVIERI NF BRITTENHAM GM KOREN G
Citation: Nf. Olivieri et al., REDUCTION IN HEPATIC IRON STORES WITH THE ORAL IRON CHELATOR L1 IN PATIENTS (PTS) WITH TRANSFUSION-DEPENDENT THALASSEMIA (HBT) AND SICKLE-CELL DISEASE (SCD) - 1ST 3 YEARS OF THE CANADIAN TRIAL, Blood, 82(10), 1993, pp. 10000313-10000313
NEED FOR EARLY, LOW-DOSE CHELATION-THERAPY IN YOUNG-CHILDREN WITH TRANSFUSED HOMOZYGOUS BETA-THALASSEMIA (HBT)
Authors: BERKOVITCH M COLLINS AF PAPADOURIS D WESSON D SIRNA JB BRITTENHAM GM OLIVIERI NF
Citation: M. Berkovitch et al., NEED FOR EARLY, LOW-DOSE CHELATION-THERAPY IN YOUNG-CHILDREN WITH TRANSFUSED HOMOZYGOUS BETA-THALASSEMIA (HBT), Blood, 82(10), 1993, pp. 10000359-10000359
Risultati: 1-25 | 26-50 | 51-51